Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06478407

Community Screening Study of Diabetic Retinopathy in Tianjin in 2024

Status
Recruiting
Phase
Study type
Observational
Enrollment
18,000 (estimated)
Sponsor
Li Xiaorong · Academic / Other
Sex
All
Age
Healthy volunteers
Accepted

Summary

Through this study, the investigators hope to understand the prevalence and influencing factors of diabetic retinopathy in Tianjin, improve the ability of complication detection and intervention in diabetic patients in primary medical and health institutions, and build a diabetes prevention and treatment network. The investigators should adhere to the policy of prevention first, combined with prevention and control, and explore a diabetes' prevention and control model suitable for our city. Extensive publicity and education should be carried out to improve the awareness of self-management ,improve the screening rate of diabetic retinopathy, and reduce the blindness rate.

Detailed description

West of the city, and hebei, heping and binhai new area to carry out the work, diabetic retinopathy screening on 18000 diabetic patients in fundus examination. Tianjin medical university eye hospital, project team, formed in grassroots medical institutions are responsible for screening fundus examination in patients with diabetes, related inspection including vision, computer optometry, fundus photography and optical coherence tomography angiography (OCTA), etc. Blood samples were collected from patients in Hexi District and Heping District to detect glycosylated hemoglobin. Glycated albumin, urine ACR and CO breath test were performed in Chu Hsien-I Memorial Hospital of Tianjin Medical University. Health records were established for the screening personnel after the examination

Conditions

Timeline

Start date
2024-03-28
Primary completion
2025-03-28
Completion
2025-03-28
First posted
2024-06-27
Last updated
2024-07-10

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT06478407. Inclusion in this directory is not an endorsement.